Kampanjeplan Neurocrine Biosciences
Avansert tidsplan
Enkel graf
Om selskapet Neurocrine Biosciences
Neurocrine Biosciences является публичной биофармацевтической компанией, основанной в 1992 году. Головной офис компании находится в Сан-Диего, штат Калифорния, и возглавляет генеральный директор Кевин Горман. Нейрокрин разрабатывает методы лечения неврологических и эндокринных заболеваний и расстройств.| IPO date | 1996-05-23 |
|---|---|
| ISIN | US64125C1099 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | http://www.neurocrine.com |
| Цена ао | 116.18 |
| Prisendring per dag: | +0.9172% (105.76) |
|---|---|
| Prisendring per uke: | +5.28% (101.38) |
| Prisendring per måned: | -6.75% (114.45) |
| Prisendring over 3 måneder: | -28.24% (148.73) |
| Prisendring over seks måneder: | -8.15% (116.2) |
| Prisendring per år: | -21.52% (135.99) |
| Prisendring over 3 år: | +23.85% (86.18) |
| Prisendring over 5 år: | +10.43% (96.65) |
| Prisendring over 10 år: | +88.67% (56.57) |
| Prisendring siden begynnelsen av året: | -21.83% (136.53) |
|
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
|||||||||||||||||||||||||||||||||||||
| Institusjoner | Volum | Dele, % |
|---|---|---|
| Blackrock Inc. | 13647891 | 13.72 |
| Vanguard Group Inc | 9710328 | 9.76 |
| State Street Corporation | 4063336 | 4.08 |
| Bellevue Group AG | 2430500 | 2.44 |
| Morgan Stanley | 2326294 | 2.34 |
| Renaissance Technologies, LLC | 1988546 | 2 |
| JP Morgan Chase & Company | 1735543 | 1.74 |
| Geode Capital Management, LLC | 1623124 | 1.63 |
| Janus Henderson Group PLC | 1551367 | 1.56 |
| Price (T.Rowe) Associates Inc | 1476949 | 1.48 |
| ETF | Dele, % | Lønnsomhet for året, % | Utbytte, % |
|---|---|---|---|
| PSYK ETF | 4.51 | 0 | |
| VictoryShares Nasdaq Next 50 ETF | 1.2271 | 25.65 | 0.64752 |
| Future Tech ETF | 1.15959 | 426.34 | 0.8416 |
| Principal Healthcare Innovators ETF | 1.15959 | 618.5 | 0.8416 |
| GraniteShares XOUT U.S. Large Cap ETF | 0.80826 | -4.52 | 0.28223 |
| First Trust Mid Cap US Equity Select ETF | 0.787 | 12.98 | 1.42674 |
| Donoghue Forlines Innovation ETF | 0.55247 | 10.06 | 0.89556 |
| Syntax Stratified MidCap ETF | 0.36602 | 17.66 | 1.56212 |
| FCF US Quality ETF | 0.29911 | 18.99 | 1.58997 |
| iShares Morningstar Mid-Cap Growth ETF | 0.22135 | 458.38 | 0.94237 |
| iShares Morningstar Mid-Cap ETF | 0.1109 | 260.95 | 1.7458 |
| iShares Morningstar Large-Cap Growth ETF | 0.04883 | 291.4 | 0.5823 |
| iShares Factors US Growth Style ETF | 0.03532 | 7.44 | 0.7035 |
| Columbia U.S. ESG Equity Income ETF | 0.02679 | -99.18 | 1.44131 |
| iShares Morningstar Large-Cap ETF | 0.02418 | 257.57 | 1.41244 |
| 0.76 | 153.48 | 0.99 |
| Veileder | Stillingstittel | Betaling | Fødselsår |
|---|---|---|---|
| Mr. Matthew C. Abernethy | Chief Financial Officer | 1.04M | 1980 (45 år) |
| Mr. Eric S. Benevich | Chief Commercial Officer | 805k | 1965 (60 år) |
| Jane Sorensen | Head of Investor Relations | N/A | |
| Ms. Julie S. Cooke | Chief Human Resources Officer | N/A | 1966 (59 år) |
| Dr. Kevin C. Gorman Ph.D. | CEO & Director | 1.9M | 1958 (67 år) |
| Dr. Jude Onyia Ph.D. | Chief Scientific Officer | 621.66k | 1964 (61 år) |
| Dr. Eiry Wyn Roberts M.D. | Chief Medical Officer | 1.04M | 1964 (61 år) |
| Mr. Darin M. Lippoldt Esq. | Chief Legal Officer & Corporate Secretary | 921.01k | 1966 (59 år) |
| Mr. Kyle W. Gano Ph.D. | Chief Business Development & Strategy Officer | 921.52k | 1973 (52 år) |
| Mr. David Warren Boyer | Chief Corporate Affairs Officer | N/A | 1980 (45 år) |
Adresse: United States, San Diego, 12780 El Camino Real - åpne i Google maps, åpne Yandex-kart
Nettsted: http://www.neurocrine.com
Nettsted: http://www.neurocrine.com
